Literature DB >> 1973501

Possible mechanism of action of deprenyl in parkinsonism.

I A Paterson, A V Juorio, A A Boulton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1973501     DOI： 10.1016/0140-6736(90)91709-j

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Restoration and putative protection in Parkinsonism.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  New mechanisms of action of irreversible monoamine oxidase type B inhibitors.

Authors:  X M Li; A V Juorio; I A Paterson; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

Review 3.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

4.  Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential.

Authors:  John P M Finberg
Journal:  Rambam Maimonides Med J       Date:  2010-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.